2-(Benzyloxy)-N-methylaniline hydrochloride, 97%, 5g

n-(Prop-2-yn-1-yl)piperazine-1-sulfonamide hydrochloride, 97%, 250mg

di-tert-Butyl (S)-2-(2-hydroxyethyl)piperazine-1,4-dicarboxylate, 95+%, 250mg

cis-1,2-Cyclohexanedicarboxylic Anhydride>99.0%(GC)25g

Methyl 2-oxotetrahydrofuran-3-carboxylate, 95.0%, 1g

4-Iodo-2,2-dimethyltetrahydro-2H-pyran, 97%, 25g

2-(2-Thienylidene)-3,4-dimethoxyacetophenone, 98.0%, 5g

Acetic acid isobutyl ester, min. 99%, for synthesis, 1 l, glass packaging

N-(1H-Indol-5-yl)acetamide, 95.0%, 5g

TERT-BUTYL (R)-2-(2-AMINOTHIAZOL-4-YL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 100mg

2-Hydroxyacetic acid, 98.0%, 25g

2-[4-(aminomethyl)phenyl]ethan-1-ol, 97%, 10g

Direct displacement pipette MICROMAN® E, 100 to 1000 µl, 1 piece